Analysis of LSL PHARMA GROUP SECURES NEW STERI-MED COMMERCIAL AGREEMENTS EXPECTED TO GENERATE OVER $4 MILLION IN RECURRING ANNUAL REVENUES AND APPOINTS ALAIN R. DUGAL AS NEW EVP & COO - aVenture Research
newswire.ca
LSL PHARMA GROUP SECURES NEW STERI-MED COMMERCIAL AGREEMENTS EXPECTED TO GENERATE OVER $4 MILLION IN RECURRING ANNUAL REVENUES AND APPOINTS ALAIN R. DUGAL AS NEW EVP & COO
BOUCHERVILLE, QC, May 28, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce the signing of a multi-year supply agreement for the distribution of Erythromycin manufactured by its subsidiary Steri-Med Pharma Inc. ("Steri-Med") to hospitals located outside the Province of Québec. In addition, SterisporinTM, our over-the-counter ophthalmic ointment product, also manufactured by Steri-Med, has rece